Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society

Frederic Baron*, Pierre Zachee, Johan Maertens, Tessa Kerre, Aurelie Ory, Laurence Seidel, Carlos Graux, Philippe Lewalle, Michel Van Gelder, Koen Theunissen, Evelyne Willems, Marie-Paule Emonds, Ann De Becker, Yves Beguin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Web of Science)
Original languageEnglish
Article number4
Number of pages8
JournalJournal of Hematology & Oncology
Volume8
DOIs
Publication statusPublished - 6 Feb 2015

Keywords

  • allo-HCT
  • Non-myeloablative conditioning
  • TBI
  • TLI
  • ATG
  • GVHD
  • Graft-versus-leukemia effects

Cite this